{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:04:50Z","timestamp":1795053890210,"version":"4.10.2"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Medications are a relatively common cause of acute kidney injury (AKI), especially in hospitalized patients who are exposed to numerous agents. Drug-related acute tubular\/tubulointerstitial injury is the most common cause of AKI associated with these agents. Toxic effects of drugs and their renal handling often lead to various forms of AKI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The inherent nephrotoxicity of drugs and their transport and metabolism by the kidneys play an important role in the occurrence of acute tubular injury. Apical transport of the aminoglycosides by endocytosis and apical pinocytosis of filtered hydroxyethyl starch into cells lead to acute tubular dysfunction. Transport of tenofovir and cisplatin by organic anion and cation transporters in the basolateral surface of the proximal tubule, respectively, are associated with intracellular drug accumulation and injury. Intratubular deposition of drug crystals with associated AKI occurs with several drugs, in particular the anticancer agent methotrexate. A potentially new mechanism of drug-induced AKI was described with vancomycin \u2013 acute vancomycin-related cast nephropathy. Immune-mediated acute tubulointerstitial injury is another cause of drug-induced AKI, as seen with immune checkpoint inhibitors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Drugs lead to AKI through mechanisms that involve their inherent toxicity as well as their transport and handling by the kidneys.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000653","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T12:25:32Z","timestamp":1567599932000},"page":"550-557","source":"Crossref","is-referenced-by-count":126,"title":["Drug-induced acute kidney injury: diverse mechanisms of tubular injury"],"prefix":"10.1097","volume":"25","author":[{"given":"Mark A.","family":"Perazella","sequence":"first","affiliation":[{"name":"Section of Nephrology, Department of Medicine, Yale University, New Haven"},{"name":"Section of Nephrology, Department of Medicine, Veterans Affairs Medical Center, West Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/ki.2010.475","article-title":"Drug use and nephrotoxicity in the ICU","volume":"81","author":"Perazella","year":"2012","journal-title":"Kidney Int"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cccn.2004.09.005","article-title":"Drug-induced renal failure: focus on tubulointerstitial disease","volume":"351","author":"Markowitz","year":"2005","journal-title":"Clin Chim Acta"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/14740338.4.4.689","article-title":"Drug-induced nephropathy: an update","volume":"4","author":"Perazella","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000441-200306000-00006","article-title":"Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity","volume":"325","author":"Perazella","year":"2003","journal-title":"Am J Med Sci"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","article-title":"Crystal-induced acute renal failure","volume":"106","author":"Perazella","year":"1999","journal-title":"Am J Med"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ckj\/sfu105","article-title":"Crystalline-induced kidney disease: a case for urine microscopy","volume":"8","author":"Luciano","year":"2015","journal-title":"Clin Kidney J"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2016080867","article-title":"Vancomycin-associated cast nephropathy","volume":"28","author":"Luque","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Markowitz","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003088-200342050-00007","article-title":"Aminoglycoside dosages and nephrotoxicity","volume":"42","author":"Rougier","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1179\/joc.2001.13.5.461","article-title":"Renal transport of antibiotics and nephrotoxicity: a review","volume":"13","author":"Fanos","year":"2001","journal-title":"J Chemother"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2133\/dmpk.19.159","article-title":"Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity","volume":"19","author":"Nagai","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bcp.2014.05.018","article-title":"Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways","volume":"90","author":"Nagai","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"R15-20230913","first-page":"1071","article-title":"Pathophysiology of nephrotoxic cell injury","author":"Cummings","year":"2001","journal-title":"Diseases of the kidney and urogenital tract"},{"key":"R16-20230913","first-page":"1137","article-title":"Antibiotic and immunosuppression-related renal failure","author":"Kaloyanides","year":"2001","journal-title":"Diseases of the kidney and urogenital tract"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","article-title":"Intravenous immunoglobulin and the kidney \u2013 a two-edged sword","volume":"34","author":"Orbach","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","article-title":"Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes","volume":"51","author":"Dickenmann","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ki.2010.344","article-title":"Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy","volume":"78","author":"Perazella","year":"2010","journal-title":"Kidney Int"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/508546","article-title":"Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy","volume":"194","author":"Izzedine","year":"2006","journal-title":"J Infect Dis"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1681\/ASN.2004040256","article-title":"Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation","volume":"16","author":"Ciarimboli","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"(Suppl 7)","key":"R22-20230913","first-page":"S157","article-title":"The role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations","volume":"56","author":"Hucke","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-14-0319","article-title":"Cisplatin-induced renal injury is independently mediated by OCT2 and p53","volume":"20","author":"Sprowl","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1039\/c3ib40049b","article-title":"Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment","volume":"5","author":"Jang","year":"2013","journal-title":"Integr Biol (Camb)"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","article-title":"Roles of organic anion transporters (OATS) and urate transporter (URAT1) in the pathophysiology of human disease","volume":"9","author":"Enomoto","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically medicated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am J Pathol"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","article-title":"Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology and prevention\/therapy","volume":"30","author":"Perazella","year":"2010","journal-title":"Semin Nephrol"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-nephrology: renal toxicities of chemotherapeutic agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ki.2015.30","article-title":"New drug toxicities in the onco-nephrology world","volume":"87","author":"Perazella","year":"2015","journal-title":"Kidney Int"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cphy.c110041","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr Physiol"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.ajkd.2007.05.014","article-title":"Ciprofloxacin crystal nephropathy","volume":"50","author":"Stratta","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R32-20230913","first-page":"970","article-title":"Drug-induced kidney diseases","volume":"51","author":"Singh","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3949\/ccjm.69.4.289","article-title":"How to prevent, recognize, and treat drug-induced nephropathy","volume":"69","author":"Guo","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrneph.2009.97","article-title":"Chemotherapyassociated renal dysfunction","volume":"5","author":"Sahni","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ncpneph0622","article-title":"Renal disease in patients with cancer","volume":"3","author":"Finkel","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cbf.1627","article-title":"Decrease of adenosine deaminase activity and increase of the lipid peroxidation after acute methotrexate treatment in young rats: protective effects of grape seed extract","volume":"28","author":"Pinheiro","year":"2010","journal-title":"Cell Biochem Funct"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2215\/CJN.11011016","article-title":"Vancomycin and the risk of AKI: now clearer than Mississippi mud","volume":"11","author":"Nolin","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R38-20230913","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"R39-20230913","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"R40-20230913","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00264-18","article-title":"Incidence of acute kidney injury among patients treated with piperacillin-tazobactam or meropenem in combination with vancomycin","volume":"62","author":"Rutter","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R41-20230913","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijantimicag.2018.11.002","article-title":"Impact of piperacillin\/tazobactam on nephrotoxicity in patients with Gram-negative bacteraemia","volume":"53","author":"Hall","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"R42-20230913","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/toxsci\/kfn203","article-title":"Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates","volume":"107","author":"Dieterich","year":"2009","journal-title":"Toxicol Sci"},{"key":"R43-20230913","first-page":"3","article-title":"Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment","volume":"9","author":"Namrata","year":"2015","journal-title":"Iran J Kidney Dis"},{"key":"R44-20230913","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.2018050488","article-title":"Nephrotoxicity of cancer immunotherapies: past, present and future","volume":"29","author":"Perazella","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R45-20230913","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int"},{"key":"R46-20230913","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ajkd.2016.02.057","article-title":"Association of acute interstitial nephritis with programmed cell death 1 inhibitor therapy in lung cancer patients","volume":"68","author":"Shirali","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R47-20230913","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ckj\/sfy100","article-title":"Renal toxicities associated with pembrolizumab","volume":"12","author":"Izzedine","year":"2018","journal-title":"Clin Kidney J"},{"key":"R48-20230913","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40425-018-0478-8","article-title":"Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience","volume":"7","author":"Mamlouk","year":"2019","journal-title":"J Immunother Cancer"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:37:26Z","timestamp":1694633846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000653","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}